9:00am - 5:00pm

Office Hours Mon. - Fri.

800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition

Pleural Malignant Mesothelioma

Estimated Enrollment: 14

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Primary Purpose: Treatment

Study ID Numbers: UPCC 03510

Study First Received: April 27, 2010

Last Updated: December 14, 2015

Estimated Primary Completion Date: October 2012

Primary Outcome Measures:

3-month PFS rate|Estimate the distribution of progression-free and over survival

Sponsors and Collaborators:

Abramson Cancer Center of the University of Pennsylvania

Result Received: No Study Results Posted

Website Link: https://ClinicalTrials.gov/show/NCT01112293

Was this article helpful?
Views: 42